Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma04:12

Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

1.6K
This article presents a protocol to conduct the treatment of melasma by using roller microneedles in combination with tranexamic acid solution and evaluate the...
1.6K
Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures03:07

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures

1.6K
Here, we describe the modified treatment methods for wasting marmoset syndrome (WMS, also known as inflammatory bowel disease (IBD)-like disease) with tranexamic acid. We also present how to administer the therapeutic agents orally, subcutaneously, and...
1.6K
Evaluating the Effect of a Synbiotic Formulation on Alzheimer’s Disease Pathology in Drosophila01:24

Evaluating the Effect of a Synbiotic Formulation on Alzheimer’s Disease Pathology in Drosophila

102
Take a transgenic Drosophila.The brain of the Drosophila expresses the human amyloid peptide protein or APP and a cleaving enzyme.The enzyme cleaves APP, enabling the formation of beta-amyloid plaque, which leads toAlzheimer's disease or AD pathology in Drosophila.Feed the Drosophila AD model a diet containing a synbiotic formulation.The formulation contains a combination of three bioactive probiotic bacteria and a prebiotic.Inside the fly's gut, the prebiotic supports the growth and survival...
102
Intratracheal Administration of Dry Powder Formulation in Mice07:55

Intratracheal Administration of Dry Powder Formulation in Mice

12.0K
Dry powder formulations for inhalation have great potential in treating respiratory diseases. Before entering human studies, it is necessary to evaluate the efficacy of the dry powder formulation in preclinical studies. A simple and noninvasive method of the administration of dry powder in mice through the intratracheal route is...
12.0K
Formulating and Characterizing an Exosome-based Dopamine Carrier System06:08

Formulating and Characterizing an Exosome-based Dopamine Carrier System

3.6K
Here, we aimed to obtain a formulation by dopamine loading of the isolated exosomes of stem cells from Wharton's jelly mesenchymal stem cells. Exosome isolation and characterization, drug loading into the resulting exosomes, and the cytotoxic activity of the developed formulation are described in this...
3.6K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

13.8K
Here, a protocol for formulating lipid nanoparticles (LNPs) that encapsulate mRNA encoding firefly luciferase is presented. These LNPs were tested for their potency in vitro in HepG2 cells and in vivo in C57BL/6...
13.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Core Outcome Domain Set for Facial Aging.

JAMA dermatology·2026
Same author

Novel 1550-nm Nonablative Resurfacing Laser With Focal Point Technology Improves Fine Lines and Wrinkles With High Energy Delivery.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Tissue Micro-Coring Is a Safe and Effective Option for the Treatment of the Nasolabial Fold, Marionette, and Perioral Rhytids.

Lasers in surgery and medicine·2026
Same author

How We Do It: Minimally Invasive Removal of Osteoma Cutis With Novel 2,910-nm Fiber Laser-Enabled Tissue Coring.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2026
Same author

Improved Skin Quality with a Novel Topical Body Serum: Distal Thighs and Back of Hands.

Journal of cosmetic dermatology·2026
Same author

Hemodynamics and Extracardiac Causes of Cardiac Tamponade: A Diagnostic and Therapeutic Dilemma.

QJM : monthly journal of the Association of Physicians·2026

Related Experiment Video

Updated: Jan 19, 2026

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.6K

Tranexamic Acid for Melasma: Evaluating the Various Formulations.

Jordan V Wang1,2, Nikita Jhawar1,2, Nazanin Saedi1,2

  • 1Drs. Wang and Saedi are with the Department of Dermatology and Cutaneous Biology at Thomas Jefferson University in Philadelphia, Pennsylvania.

The Journal of Clinical and Aesthetic Dermatology
|September 19, 2019
PubMed
Summary

Tranexamic acid shows promise for treating melasma, a difficult skin condition. Oral tranexamic acid (TXA) offers the most improvement, though it is temporary.

Keywords:
Aestheticsdermatologymelasmaskincaretranexamic acid

More Related Videos

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

1.6K
Evaluating the Effect of a Synbiotic Formulation on Alzheimer’s Disease Pathology in Drosophila
01:24

Evaluating the Effect of a Synbiotic Formulation on Alzheimer’s Disease Pathology in Drosophila

Published on: August 7, 2025

102

Related Experiment Videos

Last Updated: Jan 19, 2026

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

1.6K
Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
03:07

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)

Published on: July 12, 2024

1.6K
Evaluating the Effect of a Synbiotic Formulation on Alzheimer’s Disease Pathology in Drosophila
01:24

Evaluating the Effect of a Synbiotic Formulation on Alzheimer’s Disease Pathology in Drosophila

Published on: August 7, 2025

102

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Melasma is a common, challenging dermatological condition.
  • Current treatments like bleaching agents, peels, and lasers offer limited efficacy.

Purpose of the Study:

  • To review different formulations of tranexamic acid (TXA) for melasma treatment.
  • To discuss future research directions for TXA in melasma.

Main Methods:

  • Review of existing studies on topical, intradermal, and oral tranexamic acid.
  • Analysis of treatment outcomes and efficacy across different formulations.

Main Results:

  • Tranexamic acid (TXA) demonstrates potential in melasma management.
  • Oral formulations of TXA have shown the most significant, yet temporary, improvements.

Conclusions:

  • Tranexamic acid is a promising agent for melasma treatment.
  • Further research is needed to optimize TXA formulations and duration for sustained melasma improvement.